23 Feb Aspect Biosystems
Tamer Mohamed, Founder and CEO
April 12 | 12:00pm | Dark Horse Consulting Ballroom
Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform how we treat disease. Aspect is applying its full-stack tissue therapeutic platform, including proprietary microfluidic 3D bioprinting technology, computational design, therapeutic cells, and materials science, to create a pipeline of allogeneic bioprinted tissues that replace or repair damaged organ functions. These tissue therapeutics are rationally engineered to be biologically functional, immune-protective, and suitable for surgical implantation.